Join to View Full Profile
Otsuka Pharmaceutical Development & Commercialization, Inc508 Carnegie CtrPrinceton, NJ 08540
Dr. Siddiqui is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Vanderbilt University Medical CenterFellowship, Child Neurology, 2006 - 2009- Vanderbilt University Medical CenterResidency, Pediatrics, 2004 - 2006
University of Alabama School of MedicineClass of 2004
Certifications & Licensure
NY State Medical License 2009 - 2026
TN State Medical License 2008 - 2016
Publications & Presentations
PubMed
- 2 citationsSex Differences in Diagnosis and Treatment Timing of Comorbid Depression/Anxiety and Disease Subtypes in Patients With ADHD: A Database Study.Uzma Siddiqui, Mitchell M Conover, Erica A Voss, David M Kern, Michelle Litvak
Journal of Attention Disorders. 2024-08-01 - 4 citationsRelapse Rates With Paliperidone Palmitate in Adult Patients With Schizophrenia: Results for the 6-Month Formulation From an Open-label Extension Study Compared to Real...Ibrahim Turkoz, Mehmet Daskiran, Uzma Siddiqui, R Karl Knight, Karen L Johnston
The International Journal of Neuropsychopharmacology. 2024-02-01 - 2 citationsComparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients wi...Ibrahim Turkoz, Joshua Wong, Benjamin Chee, Uzma Siddiqui, R Karl Knight
Therapeutic Advances in Psychopharmacology. 2023-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
